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Abstract 
Parry-Romberg syndrome is a rare neurocutaneous disorder of unknown origin. It is 
characterized by progressive facial hemiatrophy and frequently overlaps with a condition 
known as linear scleroderma ‘en coup de sabre’. Neurological involvement is frequently 
described in these patients, including migraine, facial pain and epilepsy, which represent 
the commonest neurological conditions, sometimes associated with brain abnormalities 
ipsilaterally to the skin lesions. We present a case of Parry-Romberg syndrome with 
neurological involvement in a patient with diagnosed localized scleroderma (morphea). 
 
Introduction 
Parry-Romberg syndrome (PRS) is a rare neurocutaneous disorder of unknown origin 
first described by Parry in 1825 and Romberg in 1846. It is characterized by progressive 
facial hemiatrophy of the skin, subcutaneous tissue and sometimes the adjacent 
craniofacial bones, sparing facial muscles, that affects mainly the maxillary region but 
may extend to the chin and forehead [1]. The onset is subtle, affecting mostly women 
before the age of 20 years, and disease usually progresses over 2 to 20 years and then 
enters a stable phase. Patients with early onset tend to be more severely affected [2, 3]. 
PRS can be a distinct disease entity but frequently overlaps with a condition known as 
linear scleroderma ‘en coup de sabre’. Scleroderma ‘en coup de sabre’ is a linear localized 
form of morphea, affecting the frontoparietal scalp and forehead in stripe-like sclerotic 
plaques. The skin of this area appears hard, hyperpigmented, shiny and with alopecia. The 
differential diagnosis between progressive facial hemiatrophy and linear scleroderma is 
mainly based on clinical and histopathological findings. Extracutaneous changes are 
associated both with linear scleroderma and PRS [4].  
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Hemiatrophy of the arm, trunk or leg ipsilaterally or contralaterally may be present in 
these patients, while some may have tongue atrophy and dental abnormalities. There are 
reports regarding ocular features, such as enophthalmos, uveitis and heterochromia, and 
participation of skin and hair disorders including hyperpigmentation, vitiligo and 
alopecia. Patients also report frequent hemimasticatory spasms [1]. 
Neurological disorders are more frequent in patients with upper face and scalp 
involvement. Migraine and facial pain (trigeminal neuralgia) are the commonest 
neurological conditions, and epilepsy has been described in 10% of the patients, 
sometimes associated with brain abnormalities ipsilaterally to the skin lesions [2, 4]. 
Neuroimaging findings when apparent may include hyperintense ipsilateral cortical 
and subcortical lesions, intraparenchymal calcifications and localized cerebral 
hemiatrophy, corresponding to the affected side. Patients with cerebral hemiatrophy may 
show continuous slowing and multifocal sharp waves during EEG recording [5, 6]. 
There is an ongoing debate on whether localized scleroderma and PRS are two 
different disorders or belong to the same disease spectrum. Here we present a case of a 
patient with a history of localized scleroderma who was referred to us because of 
neurological complications and was found to have progressive facial hemiatrophy as well. 
Case Report 
A 38-year-old white woman with an 8-year history of localized scleroderma diagnosed by biopsy and 
no previous neurological complaints was admitted to our department in order to investigate frequent 
headaches that she developed over the last 6 months. The headaches were constant, diffuse, with 
atypical migraine characteristics. The patient had a mild left facial hemiatrophy, jaw symptoms, 
including hemimasticatory spasms coexisting with linear scleroderma affecting the forehead ‘en coup de 
sabre’ (fig. 1) and sclerotic plaques on the lower back (fig. 2) and the neck area. The facial hemiatrophy 
had late onset and a progressive course. The neurological examination was unremarkable. She did not 
report any seizure-like symptoms or cognitive impairment. 
The brain MRI did not reveal any abnormalities affecting the ipsilateral grey or white matter, but the 
EEG recording showed paroxysmal, slow, polymorphic, sharp activity of 4–5 Hz frequency, localized in 
the right temporal region. 
The patient was treated with amitryptiline 25 mg. 
Discussion 
Progressive facial hemiatrophy (or PRS) and localized scleroderma ‘en coup de sabre’ 
are rare pathological entities of uncertain etiology, with a heterogenic spectrum of 
associated neurological complications. 
The origin of PRS varies from face or body trauma [2, 7], especially in childhood onset 
disease [8], alteration of the sympathetic ganglion or trigeminal nerve [9], infections 
including Borrelia burgdorferi [2, 10, 11], to autoimmune mechanisms. The latter is 
supported by the coexistence of PRS with other autoimmune disorders, such as thyroid 
disease, vitiligo, rheumatoid arthritis, ankylosing spondylitis and lupus erythematosus [1, 
12] and by the elevated titers of one or more autoantibodies [13]. 
We present a case of a 38-year-old woman suffering from headaches with unusual 
characteristics regarding her age, with a known history of localized scleroderma and 
newly revealed progressive facial hemiatrophy. According to reports, females have a  
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higher prevalence of both PRS and morphea with initial presentation in early childhood 
[14], but late onset, as in our case, is also described. The patient had left facial 
hemiatrophy with forehead involvement (‘en coup de sabre’) and left hemimasticatory 
spasms, which affect approximately one third of PRS patients [2]. Headache, the most 
frequent neurological presentation, was the reason of her referral to the neurological 
department. This is consistent with the general view that localized scleroderma predates 
the neurological symptoms by several years [13]. Although MRI did not reveal any 
structural brain lesions [15], her EEG findings had contralateral abnormal activity, 
without a clinical presentation of epilepsy. 
The relationship between linear scleroderma and progressive facial hemiatrophy is not 
yet clearly understood. Although there are different diagnostic criteria based on distinct 
clinical and histopathological findings related to the different pathophysiological 
mechanisms attributed to these two entities [16], there are many reports about their 
coexistence and their common extracutaneous features. Sommer et al. [17] reported that 
42% of the patients with PRS had also ‘en coup de sabre’ lesions. Blaszczyk et al. [6] also 
stress the close relationship of morphea and PRS based on their mutual central nervous 
system involvement. The same conclusion was drawn by Kister et al. [13]. Tollefson and 
Witman [4] confirmed these results, and they also reported that 36.6% of patients with 
linear scleroderma also had PRS. It was also described that biopsy specimens from PRS 
patients who did not have cutaneous sclerosis showed findings consistent with morphea. 
Migraine and trigeminal neuralgia are the commonest neurological features of PRS 
with a frequency reaching 52% [1, 2]. There are reports associating these neurological 
symptoms with peripheral sympathetic nervous system or trigeminal nerve abnormalities 
[11, 12] and others support the presence of vascular dysgenesis [18–20]. 
PRS is generally considered as a self-limited disease and the need for treatment arises 
from the coexistence of localized scleroderma or other autoimmune disorders. In case of 
localized scleroderma, methotrexate and corticosteroids are the treatment of choice, while 
other immunosuppressant agents like cyclophosphamide, cyclosporine, D-penicillamine 
and hydroxychloroquine are used when more aggressive therapy is required [4, 21]. 
Reconstructive surgery, which includes fat injections, silicon implants, dermis-fat grafts, 
galeal flaps and bone and cartilage grafts, is beneficial in the cases of disfiguring facial 
atrophy [7, 22, 23]. 
In conclusion, linear scleroderma and progressive facial hemiatrophy are closely 
related forms of cranial facial scleroderma with common neurological manifestations, but 
their sole existence in some cases and their different histopathological characteristics and 
treatment approach make the definite thesis of disease overlapping still part of a 
continuous debate. 
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Fig. 1. Presence of linear morphea ‘en coup de sabre’ affecting the forehead. 
 
 
 
Fig. 2. Sclerotic plaque localized on the lower back. 
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